Unity Biotechnology, Inc.·4

Apr 3, 4:15 PM ET

Ghosh Anirvan 4

4 · Unity Biotechnology, Inc. · Filed Apr 3, 2025

Insider Transaction Report

Form 4
Period: 2025-04-02
Ghosh Anirvan
DirectorChief Executive Officer
Transactions
  • Sale

    Common Stock, $0.0001 par value

    2025-04-02$1.03/sh96,797$99,701153,454 total
Footnotes (2)
  • [F1]Shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading instruction to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
  • [F2]Includes Restricted Stock Units which vest over time measured from the grant date.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4